The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of clinic characteristics on the adoption of a guideline-based standing order algorithm and patient accrual in the pragmatic cluster-randomized trial SWOG S1415CD (NCT02728596).
 
Kate Watabayashi
No Relationships to Disclose
 
Ari Bell-Brown
No Relationships to Disclose
 
Kathryn Egan
No Relationships to Disclose
 
Karma L. Kreizenbeck
No Relationships to Disclose
 
Gary H. Lyman
Leadership - Generex Biotechnology
Consulting or Advisory Role - Coherus Biosciences; G1 Therapeutics; Halozyme
Research Funding - Amgen (Inst)
 
Dawn L. Hershman
No Relationships to Disclose
 
Aasthaa Bansal
No Relationships to Disclose
 
William E. Barlow
Research Funding - AstraZeneca (Inst); Merck (Inst)
 
Sean D Sullivan
No Relationships to Disclose
 
Scott David Ramsey
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Kite, a Gilead company; Seagen
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Bristol-Myers Squibb; Flatiron Health